Oral Abstract Session
Monogenic Kidney Disease: Mechanistic Insights and Therapeutic Approaches
November 07, 2025 | 04:30 PM - 06:00 PM
Location: Room 360A, Convention Center
Session Description
Oral Abstract Session
Note: Continuing education credits are not being offered for this session.
Learning Pathway(s)
- Genetic Diseases and Development
Moderators
Presentations
- Alternative Splicing Dysregulation by Pin1 Mediates Tuberous Sclerosis Kidney Disease
04:30 PM - 04:40 PM
- Allele-Selective Antisense Oligonucleotide Targeting Uromodulin Reduces Toxic Aggregates and Rescues Kidney Damage in Models of UMOD-Related Autosomal Dominant Tubulointerstitial Kidney Disease
04:40 PM - 04:50 PM
- Mesencephalic Astrocyte-Derived Neurotrophic Factor Orchestrates Endoplasmic Reticulum (ER)-Mitochondrial Calcium Homeostasis in Genetic CKD
04:50 PM - 05:00 PM
- Targeting Metabolic Dysfunction in Cystinosis Proximal Tubular Epithelial Cells
05:00 PM - 05:10 PM
- Deciphering the Effect of RAC1-SPTAN1 in Autosomal Recessive PKD (ARPKD) Cystogenesis Using Multifaceted Models
05:10 PM - 05:20 PM
- Endoplasmic Reticulum-Mitochondrion Disconnection Promotes Epigenetic Rewiring and Cystogenesis in PKD
05:20 PM - 05:30 PM
- Precise Editing of the Central Six Nucleotides in the Pkd1-3’UTR miR-17 Binding Motif Is Sufficient to Restore Pkd1 and Slow PKD Progression
05:30 PM - 05:40 PM
- Protective Effect of a Human Pregnancy-Associated Plasma Protein A IgG Monoclonal Antibody in an Orthologous ADPKD Mouse Model
05:40 PM - 05:50 PM
- Antisense Oligonucleotide-Mediated Polycystin 1 Upregulation by Enhancing PKD1 Translation Has the Potential to Treat ADPKD
05:50 PM - 06:00 PM